Cargando…

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome

Mesenchymal stem cell (MSC)-sourced secretome, defined as the set of MSC-derived bioactive factors (soluble proteins, nucleic acids, lipids and extracellular vesicles), showed therapeutic effects similar to those observed after transplantation of MSCs. MSC-derived secretome may bypass many side effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrell, Carl Randall, Fellabaum, Crissy, Jovicic, Nemanja, Djonov, Valentin, Arsenijevic, Nebojsa, Volarevic, Vladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562906/ https://www.ncbi.nlm.nih.gov/pubmed/31100966 http://dx.doi.org/10.3390/cells8050467

Ejemplares similares

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma
por: Harrell, C. Randall, et al.
Publicado: (2019)

Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
por: Harrell, C. Randall, et al.
Publicado: (2019)

Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Stem Cells Therapy for Spinal Cord Injury
por: Gazdic, Marina, et al.
Publicado: (2018)

Molecular mechanisms underlying therapeutic potential of pericytes
por: Harrell, C. Randall, et al.
Publicado: (2018)

Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis
por: Arsenijevic, Aleksandar, et al.
Publicado: (2017)

Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin
por: Harrell, C. Randall, et al.
Publicado: (2018)

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
por: Simovic Markovic, Bojana, et al.
Publicado: (2017)

Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
por: Acovic, Aleksandar, et al.
Publicado: (2018)

The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration
por: Miloradovic, Dragana, et al.
Publicado: (2020)

The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration
por: Harrell, Carl Randall, et al.
Publicado: (2021)

NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2023)

Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Modulation of Obstructive Sleep Apnea
por: Zdravkovic, Marija, et al.
Publicado: (2023)

Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response
por: Gazdic, Marina, et al.
Publicado: (2017)

Ethical and Safety Issues of Stem Cell-Based Therapy
por: Volarevic, Vladislav, et al.
Publicado: (2018)

Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases
por: Gazdic, Marina, et al.
Publicado: (2017)

“Derived Multiple Allogeneic Protein Paracrine Signaling (d-MAPPS)” Enhances T Cell-Driven Immune Response to Murine Mammary Carcinoma
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
por: Volarevic, Vladislav, et al.
Publicado: (2011)

Stem Cells and Labeling for Spinal Cord Injury
por: Gazdic, Marina, et al.
Publicado: (2016)

Stem Cells as New Agents for the Treatment of Infertility: Current and Future Perspectives and Challenges
por: Volarevic, Vladislav, et al.
Publicado: (2014)

Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice
por: Ljujic, Biljana, et al.
Publicado: (2013)

Disagreements in the therapeutic use of mesenchymal stem cell-derived secretome
por: Sipos, Ferenc, et al.
Publicado: (2022)

Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis
por: Simovic Markovic, Bojana, et al.
Publicado: (2016)

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016)

Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases
por: Wang, Yu, et al.
Publicado: (2020)

The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
por: Cunningham, Catriona J, et al.
Publicado: (2018)

Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding
por: Jovicic, Nemanja, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ldgo58tnnhi9ucpq5mhmgqakuo